Profit

Lupin on its strategic tie-up with Merck

PUBLISHED ON: July 18, 2013 | Duration: 6 min, 43 sec

  
loading..
Shakti Chakraborty, group president (India and CIS) of Lupin, talks to NDTV Profit about the company's strategic tie-up with Merck Sharp & Dohme for a pneumonia prevention vaccine. Mr Chakraborty says the company is likely to see tremendous growth with the vaccine as awareness grows about pneumococcal infection prevention.
ALSO WATCH
धोनी के दस्तानों पर हुए विवाद पर क्या है युवा क्रिकेटरों की राय

................................ Advertisement ................................

................................ Advertisement ................................